Outpatient Oncology Infusion Market Size

Outpatient Oncology Infusion Market Size

Outpatient Oncology Infusion Market size was valued at USD 2.4 billion in 2023 and is expected to exhibit growth at a CAGR of 10.6% from 2024 to 2032. High market growth is driven by technological advancements in infusion pumps, the increasing prevalence of cancer, and the expansion of healthcare policies and insurance coverage. These factors support the shift toward outpatient treatments, which are favored for their cost-effectiveness and efficiency.

To get key market trends

  Download Free Sample

Cancer is a major public health issue across the globe. This is owing to the surging cancer cases and mortality rate. For instance, according to the American Cancer Society, in 2021, around 608,570 cancer deaths occurred in the U.S. Also stated that breast cancer is the most common type of cancer on the list, with 284,200 new cases in the U.S. 2021. Prostate cancer and lung cancer are the next most common cancers. Therefore, the high burden of cancer is increasing the demand for infusion therapy and drug infusion system, thereby contributing to the market growth.

Outpatient oncology infusion is the administration of chemotherapy, cancer immunotherapy, or other cancer treatments in an outpatient setting rather than in a hospital. Patients visit a specialized clinic or infusion center to receive their medications intravenously. This approach allows patients to spend less time in medical facilities and more time at home, improving their quality of life.